MedPath

Role of Ayurveda in the management of Psoriasis (Ekakushtha).

Phase 3
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2024/05/066611
Lead Sponsor
Institute Of Teaching and Research In Ayurveda ,JAMNAGER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having signs and symptoms of Ekakushtha (Psoriasis) which are mentioned in

diagnostic criteria.

Exclusion Criteria

Diseases like Juvenile Diabetes, CHD, TB, HIV & other chronic diseases.

Patients with Nail Psoriasis, Guttate Psoriasis, Inverse Psoriasis.

Virechana Ayogya patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reduction in Aswedana <br/ ><br>2. Reduction in Mahavastu <br/ ><br>3. Reduction in Matsya Shakalopama <br/ ><br>4. Reduction in Daha. <br/ ><br>5. Reduction in Kandu. <br/ ><br>Timepoint: 42 DAYS
Secondary Outcome Measures
NameTimeMethod
PSAI score reductionTimepoint: 42 Days
© Copyright 2025. All Rights Reserved by MedPath